Hikmat A. Al-Ahmadie, MD
Pathologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Attending Pathologist
I am a board-certified pathologist in anatomic and clinical pathology with expertise in the surgical pathology of tumors of the genitourinary system. Within our group, every year we examine thousands of biopsies and resections from tumors of the prostate, kidney, bladder, and testis. This enables us to establish the correct diagnosis and the extent of these tumors.
Read more
Of particular academic interest to me are tumors that develop in the urinary bladder. Currently I am researching the molecular and genetic aberrations of these tumors to identify markers that could help with prognosis and treatment decisions. This research is being conducted both in the Department of Pathology as well as through collaborations with other investigators at Memorial Sloan Kettering Cancer Center.
I also serve as one of the principal investigators from Memorial Sloan Kettering in the study of bladder cancer conducted through The Cancer Genome Atlas (TCGA) — a national effort coordinated by the National Cancer Institute and the National Human Genome Research Institute to improve the ability to diagnose, treat, and prevent cancer through a systematic exploration of all genomic changes that occur in human cancers.
See Hikmat A. Al-Ahmadie’s laboratory research at Memorial Sloan Kettering.
A pathologist is a doctor who uses a microscope to make a diagnosis from cell and tissue samples. They analyze the samples to learn the cause and effects of a health condition.
My Specialties
- Genitourinary Pathology
Education
- MD, Damascus University Faculty of Medicine (Syria)
Residencies
- American University of Beirut
- University of Cincinnati College of Medicine
Fellowships
- Memorial Sloan Kettering Cancer Center
Board Certifications
- Anatomic Pathology
- Clinical Pathology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Request an Opinion
Request an Opinion
Current Patients
Contact and Location
Dr. Al-Ahmadie sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Al-Ahmadie
- A Phase III Study of Padeliporfin Vascular Targeted Photodynamic Therapy in People with Upper Tract Urothelial Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Al-Ahmadie’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Hikmat A. Al-Ahmadie discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
Paige.AI, Inc.
Professional Services and Activities (Uncompensated)
-
Pfizer, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.